Advertisement
Screener

SCYNEXIS, Inc. (SCYX) Share-based Payment Arrangement, Expense

2.8 / 5 stars · 68/120 Roast Me

SCYNEXIS, Inc. Share-based Payment Arrangement, Expense

SCYNEXIS, Inc. (SCYX) reported Share-based Payment Arrangement, Expense of $568.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-10

  • SCYNEXIS, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $568.00K, a 30.73% decline year-over-year.
  • SCYNEXIS, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $580.00K, a 29.18% decline year-over-year.
  • SCYNEXIS, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $687.00K, a 29.97% decline year-over-year.
  • SCYNEXIS, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $526.00K, a 41.62% decline year-over-year.
  • SCYNEXIS, Inc. share-based payment arrangement, expense for fiscal 2025 was $2.85M, a 14.76% decline from fiscal 2024.
  • SCYNEXIS, Inc. share-based payment arrangement, expense for fiscal 2024 was $3.35M, a 27.52% increase from fiscal 2023.
  • SCYNEXIS, Inc. share-based payment arrangement, expense for fiscal 2023 was $2.62M, a 25.28% decline from fiscal 2022.
  • SCYNEXIS, Inc. share-based payment arrangement, expense for fiscal 2022 was $3.51M, a 68.20% increase from fiscal 2021.
Period endShare-based Payment Arrangement, ExpenseShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2026-06-30$568.00K
10-Q · filed 2026-08-10
$1.15M
10-Q · filed 2026-08-10
$1.83M
derived: sum of 3 quarters · filed 2026-08-10
$2.36M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31$580.00K
10-Q · filed 2026-05-11
$1.27M
derived: sum of 2 quarters · filed 2026-05-11
$1.79M
derived: sum of 3 quarters · filed 2026-05-11
$2.61M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31$687.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$1.21M
derived: sum of 2 quarters · filed 2026-03-04
$2.03M
derived: sum of 3 quarters · filed 2026-08-10
$2.85M
10-K · filed 2026-03-04
2025-09-30$526.00K
10-Q · filed 2025-11-05
$1.35M
derived: sum of 2 quarters · filed 2026-08-10
$2.17M
10-Q · filed 2025-11-05
$3.15M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30$820.00K
10-Q · filed 2026-08-10
$1.64M
10-Q · filed 2026-08-10
$2.62M
derived: sum of 3 quarters · filed 2026-08-10
$3.52M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$819.00K
10-Q · filed 2026-05-11
$1.80M
derived: sum of 2 quarters · filed 2026-05-11
$2.70M
derived: sum of 3 quarters · filed 2026-05-11
$3.46M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31$981.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$1.88M
derived: sum of 2 quarters · filed 2026-03-04
$2.64M
derived: sum of 3 quarters · filed 2026-03-04
$3.35M
10-K · filed 2026-03-04
2024-09-30$901.00K
10-Q · filed 2025-11-05
$1.66M
derived: sum of 2 quarters · filed 2025-11-05
$2.37M
10-Q · filed 2025-11-05
$2.92M
derived: sum of 4 quarters · filed 2025-11-05
2024-06-30$759.00K
10-Q · filed 2025-08-13
$1.46M
10-Q · filed 2025-08-13
$2.02M
derived: sum of 3 quarters · filed 2025-08-13
$2.65M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$705.00K
10-Q · filed 2025-05-15
$1.26M
derived: sum of 2 quarters · filed 2025-05-15
$1.89M
derived: sum of 3 quarters · filed 2025-05-15
$2.62M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$557.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12
$1.19M
derived: sum of 2 quarters · filed 2025-03-12
$1.92M
derived: sum of 3 quarters · filed 2025-03-12
$2.62M
10-K · filed 2025-03-12
2023-09-30$632.00K
10-Q · filed 2024-11-06
$1.36M
derived: sum of 2 quarters · filed 2024-11-06
$2.07M
10-Q · filed 2024-11-06
$2.52M
derived: sum of 4 quarters · filed 2024-11-06
2023-06-30$728.00K
10-Q · filed 2024-08-08
$1.44M
10-Q · filed 2024-08-08
$1.89M
derived: sum of 3 quarters · filed 2024-08-08
$2.92M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$707.00K
10-Q · filed 2024-05-08
$1.16M
derived: sum of 2 quarters · filed 2024-05-08
$2.20M
derived: sum of 3 quarters · filed 2024-05-08
$3.30M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$453.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$1.49M
derived: sum of 2 quarters · filed 2024-03-28
$2.59M
derived: sum of 3 quarters · filed 2024-03-28
$3.51M
10-K · filed 2024-03-28
2022-09-30$1.04M
10-Q · filed 2023-11-13
$2.14M
derived: sum of 2 quarters · filed 2023-11-13
$3.06M
10-Q · filed 2023-11-13
$3.62M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$1.10M
10-Q · filed 2023-08-14
$2.02M
10-Q · filed 2023-08-14
$2.58M
derived: sum of 3 quarters · filed 2023-08-14
$3.17M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$922.00K
10-Q · filed 2023-05-10
$1.48M
derived: sum of 2 quarters · filed 2023-05-10
$2.07M
derived: sum of 3 quarters · filed 2023-05-10
$2.61M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$560.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$1.15M
derived: sum of 2 quarters · filed 2023-03-31
$1.69M
derived: sum of 3 quarters · filed 2023-03-31
$2.09M
10-K · filed 2023-03-31
2021-09-30$588.00K
10-Q · filed 2022-11-09
$1.13M
derived: sum of 2 quarters · filed 2022-11-09
$1.53M
10-Q · filed 2022-11-09
$2.53M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$542.00K
10-Q · filed 2022-08-15
$940.00K
10-Q · filed 2022-08-15
$1.94M
derived: sum of 3 quarters · filed 2022-08-15
$2.34M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$398.00K
10-Q · filed 2022-05-12
$1.40M
derived: sum of 2 quarters · filed 2022-05-12
$1.80M
derived: sum of 3 quarters · filed 2022-05-12
$2.21M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$1.40M
derived: sum of 2 quarters · filed 2022-03-29
$1.81M
derived: sum of 3 quarters · filed 2022-03-29
$2.22M
10-K · filed 2022-03-29
2020-09-30$399.00K
10-Q · filed 2021-11-10
$810.00K
derived: sum of 2 quarters · filed 2021-11-10
$1.22M
10-Q · filed 2021-11-10
$1.66M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$411.00K
10-Q · filed 2021-08-16
$821.00K
10-Q · filed 2021-08-16
$1.26M
derived: sum of 3 quarters · filed 2021-08-16
$1.71M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31$410.00K
10-Q · filed 2021-05-17
$851.00K
derived: sum of 2 quarters · filed 2021-05-17
$1.30M
derived: sum of 3 quarters · filed 2021-05-17
$1.75M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$441.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29
$890.00K
derived: sum of 2 quarters · filed 2021-03-29
$1.34M
derived: sum of 3 quarters · filed 2021-03-29
$1.83M
10-K · filed 2021-03-29
2019-09-30$449.00K
10-Q · filed 2020-11-06
$895.00K
derived: sum of 2 quarters · filed 2020-11-06
$1.39M
10-Q · filed 2020-11-06
$1.85M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30$446.00K
10-Q · filed 2020-08-10
$938.00K
10-Q · filed 2020-08-10
$1.40M
derived: sum of 3 quarters · filed 2020-08-10
$1.86M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$492.00K
10-Q · filed 2020-05-11
$957.00K
derived: sum of 2 quarters · filed 2020-05-11
$1.42M
derived: sum of 3 quarters · filed 2020-05-11
$1.88M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$465.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11
$923.00K
derived: sum of 2 quarters · filed 2020-03-11
$1.39M
derived: sum of 3 quarters · filed 2020-03-11
$1.82M
10-K · filed 2020-03-11
2018-09-30$458.00K
10-Q · filed 2019-11-12
$926.00K
derived: sum of 2 quarters · filed 2019-11-12
$1.35M
10-Q · filed 2019-11-12
$1.77M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$468.00K
10-Q · filed 2019-08-07
$893.00K
10-Q · filed 2019-08-07
$1.31M
derived: sum of 3 quarters · filed 2019-08-07
$1.72M
derived: sum of 4 quarters · filed 2019-08-07
2018-03-31$425.00K
10-Q · filed 2019-05-08
$846.00K
derived: sum of 2 quarters · filed 2019-05-08
$1.25M
derived: sum of 3 quarters · filed 2019-05-08
$1.69M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31$421.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$828.00K
derived: sum of 2 quarters · filed 2019-03-14
$1.27M
derived: sum of 3 quarters · filed 2019-03-14
$1.66M
10-K · filed 2019-03-14
2017-09-30$407.00K
10-Q · filed 2018-11-13
$845.00K
derived: sum of 2 quarters · filed 2018-11-13
$1.24M
10-Q · filed 2018-11-13
$1.54M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$438.00K
10-Q · filed 2018-08-09
$833.00K
10-Q · filed 2018-08-09
$1.14M
derived: sum of 3 quarters · filed 2018-08-09
$1.43M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$396.00K
10-Q · filed 2018-05-08
$698.00K
derived: sum of 2 quarters · filed 2018-05-08
$991.00K
derived: sum of 3 quarters · filed 2018-05-08
$1.33M
derived: sum of 4 quarters · filed 2018-05-08
2016-12-31$302.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
$595.00K
derived: sum of 2 quarters · filed 2018-03-13
$937.00K
derived: sum of 3 quarters · filed 2018-03-13
$1.21M
10-K · filed 2018-03-13
2016-09-30$293.00K
10-Q · filed 2017-11-07
$635.00K
derived: sum of 2 quarters · filed 2017-11-07
$908.00K
10-Q · filed 2017-11-07
$1.28M
derived: sum of 4 quarters · filed 2017-11-07
2016-06-30$342.00K
10-Q · filed 2017-08-08
$616.00K
10-Q · filed 2017-08-08
$983.00K
derived: sum of 3 quarters · filed 2017-08-08
$2.52M
derived: sum of 4 quarters · filed 2017-08-08
2016-03-31$274.00K
10-Q · filed 2017-05-08
$641.00K
derived: sum of 2 quarters · filed 2017-05-08
$2.18M
derived: sum of 3 quarters · filed 2017-05-08
$3.00M
derived: sum of 4 quarters · filed 2017-05-08
2015-12-31$367.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$1.91M
derived: sum of 2 quarters · filed 2017-03-13
$2.73M
derived: sum of 3 quarters · filed 2017-03-13
$3.02M
10-K · filed 2017-03-13
2015-09-30$1.54M
10-Q · filed 2016-11-07
$2.36M
derived: sum of 2 quarters · filed 2016-11-07
$2.66M
10-Q · filed 2016-11-07
$3.02M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30$819.00K
10-Q · filed 2016-08-08
$1.11M
10-Q · filed 2016-08-08
$1.48M
derived: sum of 3 quarters · filed 2017-03-13
$1.93M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$296.00K
10-Q · filed 2016-05-09
$660.00K
derived: sum of 2 quarters · filed 2017-03-13
$1.11M
derived: sum of 3 quarters · filed 2017-03-13
$1.39M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31$364.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$819.00K
derived: sum of 2 quarters · filed 2017-03-13
$1.09M
derived: sum of 3 quarters · filed 2017-03-13
$1.20M
10-K · filed 2017-03-13
2014-09-30$455.00K
10-Q · filed 2015-11-13
$727.00K
derived: sum of 2 quarters · filed 2015-11-13
$837.00K
10-Q · filed 2015-11-13
$908.00K
derived: sum of 4 quarters · filed 2015-11-13
2014-06-30$272.00K
10-Q · filed 2015-08-19
$382.00K
10-Q · filed 2015-08-19
$453.00K
derived: sum of 3 quarters · filed 2015-10-30
$479.00K
derived: sum of 4 quarters · filed 2015-10-30
2014-06-18$0.00
10-Q · filed 2014-08-13
2014-03-31$110.00K
8-K · filed 2015-10-30
$181.00K
derived: sum of 2 quarters · filed 2015-10-30
$207.00K
derived: sum of 3 quarters · filed 2015-10-30
$249.00K
derived: sum of 4 quarters · filed 2015-10-30
2013-12-31$71.00K
derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30
$97.00K
derived: sum of 2 quarters · filed 2015-10-30
$139.00K
derived: sum of 3 quarters · filed 2015-10-30
$180.00K
8-K · filed 2015-10-30
2013-09-30$26.00K
10-Q · filed 2014-11-13
$68.00K
derived: sum of 2 quarters · filed 2014-11-13
$109.00K
10-Q · filed 2014-11-13
2013-06-30$42.00K
10-Q · filed 2014-08-13
$83.00K
10-Q · filed 2014-08-13
2013-03-31$42.00K
10-Q/A · filed 2014-07-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
PDS Biotechnology Corp (PDSB)United States$0.045B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
VERU INC. (VERU)United States$0.043B-3.93
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98